187 results on '"Maguire, David R."'
Search Results
2. Drug Addiction and Drug Dependency
3. Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys
4. Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
5. Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
6. Drug Addiction and Drug Dependency
7. Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects
8. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
9. Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure.
10. OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects
11. Characterizing a Monoclonal Antibody for the Reversal and Prevention of Fentanyl-Induced Hypoventilation in Rhesus Monkeys
12. OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention
13. Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist
14. Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
15. Developing Improved Translational Models of Pain: A Role for the Behavioral Scientist
16. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
17. Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys
18. Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task
19. Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio
20. Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
21. Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys
22. Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats
23. Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure
24. Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl
25. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
26. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys
27. Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder
28. Effects of amphetamine on delay discounting in rats depend upon the manner in which delay is varied
29. Effects of daily morphine treatment on impulsivity in rats responding under an adjusting stop-signal reaction time task
30. Developing Improved Translational Models of Pain: A Role for the Behavioral Scientist
31. Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
32. Impulsivity and drugs of abuse: A juice-reinforced operant procedure for determining within-session delay discounting functions in rhesus monkeys
33. Chapter One - Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects
34. Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys
35. Interactions between Fentanyl and 2,5‐dimethoxy‐4‐methylamphetamine (DOM), a 5‐HT2AReceptor Agonist, in Rhesus Monkeys Responding under a Food Versus Drug Choice Procedure
36. Effects of cannabidiol (CBD), ∆ 9 ‐tetrahydrocannabinol (THC), and CBD/THC mixtures on fentanyl self‐administration in a food drug choice procedure in rhesus monkeys
37. Interactions between impulsivity and MDPV self‐administration in rats
38. Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys
39. Delay discounting of the μ-opioid receptor agonist remifentanil in rhesus monkeys
40. Effect of daily morphine administration and its discontinuation on delay discounting of food in rhesus monkeys
41. Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats
42. Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation
43. Delay discounting of food and remifentanil in rhesus monkeys
44. Effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) and quipazine on heroin self-administration in rhesus monkeys
45. Countermeasures for Preventing and Treating Opioid Overdose
46. Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures
47. Effects of Acute and Repeated Methocinnamox Treatment on Fentanyl Self‐administration in Rhesus Monkeys
48. Methocinnamox (MCAM) Reverses and Provides Extended Protection from Fentanyl‐Induced Respiratory Depression in Awake Unrestrained Rats
49. OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention
50. Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.